Revolutionary 'Junk' DNA Could Combat Drug-Resistant Blood Cancer

Researchers have discovered that activating transposable elements in certain blood cancers with specific mutations creates a vulnerability that can be exploited using PARP inhibitors, leading to cancer cell death without harming healthy cells, offering a new potential treatment for drug-resistant blood cancers.